Literature DB >> 23322997

-449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappa-B, is associated with the susceptibility to ulcerative colitis.

Ranji Hayashi1, Tomomitsu Tahara, Tsukasa Yamaaki, Takashi Saito, Kazuhiro Matsunaga, Nobuhiko Hayashi, Atsushi Fukumura, Kazuaki Ozaki, Masakatsu Nakamura, Hisakazu Shiroeda, Mikihiro Tsutsumi, Tomoyuki Shibata, Tomiyasu Arisawa.   

Abstract

AIM: To clarify the association between a polymorphism -449 C>G (rs72696119) in 5'-UTR of NFKB1 with ulcerative colitis (UC).
METHODS: The studied population comprised 639 subjects, including patients with UC (UC cases, n = 174) and subjects without UC (controls, n = 465). We employed polymerase chain reaction-single strand conformation polymorphism to detect the gene polymorphism.
RESULTS: The rs72696119 G allele frequencies in controls and UC cases were 33.4% and 38.5%, respectively (P = 0.10). Genotype frequency of the GG homozygote in UC cases was significantly higher than that in controls (P = 0.017), and the GG homozygote was significantly associated with susceptibility to UC [odds ratio (OR), 1.88; 95%CI, 1.13-3.14]. In male subjects, the GG homozygote was associated with an increased risk for UC (OR, 3.10; 95%CI, 1.47-6.54; P = 0.0053), whereas this association was not found in female subjects. In addition, the GG homozygote was significantly associated with the risk of non-continuous disease (OR, 2.06; 95%CI, 1.12-3.79; P = 0.029), not having total colitis (OR, 2.40; 95%CI, 1.09-3.80, P = 0.040), disease which developed before 20 years of age (OR, 2.80; 95%CI, 1.07-7.32, P = 0.041), no hospitalization (OR, 2.28; 95%CI, 1.29-4.05; P = 0.0090) and with a maximum of 8 or less on the UCDAI score (OR, 2.45; 95%CI, 1.23-4.93; P = 0.022).
CONCLUSION: Our results provide evidence that NFKB1 polymorphism rs72696119 was significantly associated with the development of UC. This polymorphism influences the susceptibility to and pathophysiological features of UC.

Entities:  

Keywords:  Genetic polymorphism; NFKB1; Ulcerative colitis

Mesh:

Substances:

Year:  2012        PMID: 23322997      PMCID: PMC3531683          DOI: 10.3748/wjg.v18.i47.6981

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 2.  Inflammatory bowel disease (2)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

3.  Activation of nuclear factor kappa B inflammatory bowel disease.

Authors:  S Schreiber; S Nikolaus; J Hampe
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

4.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

5.  Course of ulcerative colitis: analysis of changes in disease activity over years.

Authors:  E Langholz; P Munkholm; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

6.  A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock.

Authors:  Mihaela Gadjeva; Michal F Tomczak; Ming Zhang; Yan Yan Wang; Karen Dull; Arlin B Rogers; Susan E Erdman; James G Fox; Michael Carroll; Bruce H Horwitz
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

7.  Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.

Authors:  L Lin; G N DeMartino; W C Greene
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively.

Authors:  M M Le Beau; C Ito; P Cogswell; R Espinosa; A A Fernald; A S Baldwin
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

9.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

Authors:  J H Cho; D L Nicolae; L H Gold; C T Fields; M C LaBuda; P M Rohal; M R Pickles; L Qin; Y Fu; J S Mann; B S Kirschner; E W Jabs; J Weber; S B Hanauer; T M Bayless; S R Brant
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.

Authors:  Amir S Karban; Toshihiko Okazaki; Carolien I M Panhuysen; Thomas Gallegos; James J Potter; Joan E Bailey-Wilson; Mark S Silverberg; Richard H Duerr; Judy H Cho; Peter K Gregersen; Yuqiong Wu; Jean-Paul Achkar; Themistocles Dassopoulos; Esteban Mezey; Theodore M Bayless; Franklin J Nouvet; Steven R Brant
Journal:  Hum Mol Genet       Date:  2003-11-12       Impact factor: 6.150

View more
  1 in total

1.  A functional haplotype of NFKB1 influence susceptibility to oral cancer: a population-based and in vitro study.

Authors:  Fa Chen; Fengqiong Liu; Lingjun Yan; Lisong Lin; Yu Qiu; Jing Wang; Junfeng Wu; Xiaodan Bao; Zhijian Hu; Lin Cai; Baochang He
Journal:  Cancer Med       Date:  2018-04-10       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.